MedTrace Logo

A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin

NCT02355639 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2025-02-24

No results posted yet for this study

Summary

The purpose of this study is to assess steroid induced skin atrophy by sonography.

Conditions

  • Skin and Connective Tissue Diseases

Interventions

DRUG

Clobetasol propionate 0.05 % ointment

DRUG

Betamethasone dipropionate 0.064 % ointment

DRUG

Petrolatum ointment

Sponsors & Collaborators

  • LEO Pharma

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02355639 on ClinicalTrials.gov